| Reagan-Udall Foundation

Read more about A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.

Read more about A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

Members of the consortium have had an ongoing dialogue with the hub, Critical Path Institute, the Reagan-Udall Foundation, and AMP ALS since mid-2024.

Coverage

Read more about BioCentury: The next rare disease roadblock: American innovation moving ex-U.S.

Read more about Primary Mitochondrial Diseases

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), hosted a virtual, public workshop to explore opportunities to optimize therapeutic development to address primary mitochondrial diseases.

Read more about Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® M in Lip Augmentation

Read more about Improving Sports and Recreation Services in Mashhad for Elderly and Intergenerational Interaction (ESPIRE-M)

Subscribe to

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation

Relative Bioavailability Study of CX2101A for the Treatment of COVID-19

Enhancing Breastfeeding Self-Efficacy in Filipino Mothers: Assessing the Impact of the LactApp m-Health Tool

A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.

A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

BioCentury: The next rare disease roadblock: American innovation moving ex-U.S.

Primary Mitochondrial Diseases

Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® M in Lip Augmentation

Improving Sports and Recreation Services in Mashhad for Elderly and Intergenerational Interaction (ESPIRE-M)

Subscribe for updates from the Reagan-Udall Foundation for the FDA